Skip to content

To evaluate the dose-effect relation and efficacy by using chuanxiongchatiaosan, comprised of the different processed products of the rhizome of chuanxiong to treat the wind-attacking-type migraine

To evaluate the dose-effect relation and efficacy by using chuanxiongchatiaosan, comprised of the different processed products of the rhizome of chuanxiong to treat the wind-attacking-type migraine

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000029223
Enrollment
Unknown
Registered
2020-01-19
Start date
2020-05-01
Completion date
Unknown
Last updated
2020-01-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

migraine

Interventions

Sponsors

Beijing University of Chinese Medicine Third affiliated Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Patients are 18 to 70 years of age with a diagnosis of migraine according to western and TCM criteria, and had experienced 2 times per month in the past 3 months; 2. No preventive drugs were used before the attack, and no other traditional Chinese medicine or western medicine was used during the attack; 3. All patients participating to the clinical trial are voluntary and provide the written informed consent.

Exclusion criteria

Exclusion criteria: 1. Pregnant or nursing women; 2. Patients do not conform to the diagnosis of migraine according to the western and TCM criteria; 3. Patients suffer from other diseases, such as heart, liver, kidney, hematopoietic system and other serious primary diseases, cancers or mental diseases; 4. Headache is one of the symptoms of other diseases, such as hypertension, post-traumatic brain syndrome and organic lesions in the brain, poisoning, or systemic disease; 5. Preventive drugs were used before the attack, or other traditional Chinese medicine or western medicine was used during the attack.

Design outcomes

Primary

MeasureTime frame
Visual Analogue Score;

Secondary

MeasureTime frame
TCM syndrome comprehensive score;headache impact test-6;pittsburgh sleep quality index;

Countries

China

Contacts

Public ContactZhao Yonglie

Beijing University of Chinese Medicine Third affiliated Hospital

yongy3@126.com+86 13641086409

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026